Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer - Concepedia

Concepedia

Publication | Closed Access

Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer

52

Citations

15

References

2014

Year

K.N. Slaughter, Theresa Thai, Shayla Penaroza, Doris M. Benbrook, Elangovan Thavathiru, Kai Ding, Tina Nelson, D. Scott McMeekin, Kathleen N. Moore

Gynecologic Oncology

First-line Bevacizumab-based ChemotherapyPrognostic BiomarkersEpithelial Ovarian CancerMedicineClinical BiomarkersGynecologyCancer TreatmentOncologyRadiation OncologyEndocrine-related CancerOvarian Cancer

References

	Year	Citations

Page 1

Page 1